Literature DB >> 8393353

Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type.

B Borisch1, I Hennig, R H Laeng, E R Waelti, R Kraft, J Laissue.   

Abstract

Lethal midline granuloma (LMG) is associated with Epstein-Barr virus (EBV). The latter has at least two subtypes with different biological properties. The subtypes can be identified by their genomic configuration. Using EBV-RNA (EBER) in situ hybridization and EBV polymerase chain reaction (PCR), we have looked for the presence of EBV in six LMGs and six non-Hodgkin's lymphomas (NHLs) located in the nasopharyngeal region, and determined the subtype of EBV. Six of six LMGs were positive by PCR and EBER in situ hybridization, whereas NHLs were either negative or, in three of six cases, showed few EBER-positive cells considered to be nonneoplastic lymphocytes. The subtype 2 was found in LMG lesions of three of six patients; the remaining three of six patients with LMG had the generally occurring subtype 1. The results indicate that the association of EBV with NHL may depend more on tumor type than on its localization. The occurrence of the rare subtype 2 in LMG may relate to a covert immune defect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393353

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.

Authors:  N Mori; Y Yatabe; K Oka; T Kinoshita; T Kobayashi; T Ono; J Asai
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 2.  The Epstein-Barr virus and its association with human cancers.

Authors:  K R Baumforth; L S Young; K J Flavell; C Constandinou; P G Murray
Journal:  Mol Pathol       Date:  1999-12

3.  Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.

Authors:  M Higa; T Kinjo; K Kamiyama; T Iwamasa; T Hamada; K Iyama
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

Review 4.  Detection and characterization of Epstein-Barr virus in clinical specimens.

Authors:  R F Ambinder; R B Mann
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

5.  Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells.

Authors:  D R Martin; R L Marlowe; J M Ahearn
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Association of Epstein-Barr virus with sinonasal angiocentric T cell lymphoma.

Authors:  G O'Leary; S M Kennedy
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

7.  Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.

Authors:  Ilona Argirion; Katie R Zarins; Julie J Ruterbusch; Patravoot Vatanasapt; Hutcha Sriplung; Erlene K Seymour; Laura S Rozek
Journal:  Cancer       Date:  2019-09-16       Impact factor: 6.860

8.  Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.

Authors:  Tawatchai Pongpruttipan; Tanawan Kummalue; Anan Bedavanija; Archrob Khuhapinant; Koichi Ohshima; Fumiko Arakawa; Daisuke Niino; Sanya Sukpanichnant
Journal:  Diagn Pathol       Date:  2011-08-25       Impact factor: 2.644

Review 9.  Nasal NK/T-cell lymphoma: epidemiology and pathogenesis.

Authors:  Katsuyuki Aozasa; Tetsuya Takakuwa; Tadashi Hongyo; Woo-Ick Yang
Journal:  Int J Hematol       Date:  2008-02-08       Impact factor: 2.490

10.  Extranodal NK/T Cell Lymphoma with Destruction of the Uvulae: A Case Report.

Authors:  Farahzad Jabbari Azad; Zahra Delavarian; Masoud Hatami; Hosein Rahimi; Mohammad Reza Abdolvahed
Journal:  Iran J Otorhinolaryngol       Date:  2017-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.